Skip to main content
. Author manuscript; available in PMC: 2017 Aug 31.
Published in final edited form as: Br J Haematol. 2015 Jun 30;171(1):91–99. doi: 10.1111/bjh.13529

Figure 1.

Figure 1

Overall survival (OS) of patients with myelodysplastic syndrome with fibrosis grouped according to the Revised International Prognostics Stratification System. Patients within the very low and low risk groups according had significantly longer overall survival compared to those within other risk groups (p=0.0083).